TrialSignal transduction and targeted therapy2025

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Ying Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.